Abstract
Background: Superparamagnetic Iron Oxide Nanoparticles (SPIO) have been used as a tracer for SLN localization in breast cancer, demonstrating comparable performance to the combination of radioisotope and blue dye (RI±BD) with occasional skin staining as an adverse effect. SPIO has been tested in different doses, injection site and timing and shows the potential for delayed SLN dissection (SLND) after previous breast excision for DCIS. A systematic review and meta-analysis were undertaken to summarize evidence, assess technique evolution and define knowledge gaps.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
